Posttransplant Malignancies in Adult Renal and Hepatic Transplant Patients.
CONCLUSIONS: Despite recent positive developments in the use of immunosuppressive drugs, posttransplant malignancy is still a health problem. Fortunately, most cancers in this patient group have good prognosis and can be cured by surgical resection. Transplant physicians should aim for early detection of these diseases.
PMID: 30119617 [PubMed - as supplied by publisher]
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - Category: Transplant Surgery Authors: Rahatli S, Altundag O, Ayvazoglu Soy E, Moray G, Haberal M Tags: Exp Clin Transplant Source Type: research
More News: Cancer | Cancer & Oncology | Middle East Health | Sarcomas | Skin | Skin Graft | Study | Transplants